AUROPHARMAAurobindo Pharma Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹1,559.60
▲ 1.71%Decent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)88,228.40
P/E25.39
P/B2.35
PEG13.36
ROE %9.93
ROCE %11.00
Debt / Equity0.21
EPS60.39
Revenue Growth %5.60
Profit Growth %1.90
Dividend Yield %0.26
Promoter Holding %54.83
FII Holding %29.21
DII Holding %—
Beta0.02
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 73% | ₹1,559.60 | ₹1,520.40 | ₹1,676.00 | 2.97 |
HOLDConviction 67%
The picture
- • Debt/Equity: 0.21
- • Promoter holding: 54.8%
- • Valuation vs sector: P/E 25.4 vs sector 38.6
- • RSI: 55
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Pullback to 21-EMA signal (setup quality 73%)
Bull case
- • Debt/Equity: 0.21
- • Promoter holding: 54.8%
- • Valuation vs sector: P/E 25.4 vs sector 38.6
- • RSI: 55
Bear case
- • Revenue growth: 5.6% YoY
- • Profit growth: 1.9% YoY
- • MACD: bearish
- • Volume: 1.0x 20-day average
Key risks
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: 5.6% YoY
- • Profit growth: 1.9% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹1,559.60
Stop Loss
₹1,477.28
risk 5.3%
Target 1 (1.5R)
₹1,683.08
+7.9%
Target 2 (3R)
₹1,806.57
+15.8%
Support (20d)
₹1,492.20
Resistance (52w)
₹1,636.80
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹82.32/share
ATR (volatility)
₹36.59
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹36.59). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
44
Technical
67
Momentum
74
Risk (safety)
78